期刊
MOLECULAR PHARMACOLOGY
卷 71, 期 1, 页码 145-157出版社
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/mol.106.028365
关键词
-
资金
- NHLBI NIH HHS [R01-HL058641] Funding Source: Medline
- NIAID NIH HHS [R01-AI058300, R01-AI053703] Funding Source: Medline
- NIDA NIH HHS [R21-DA014885, R01-DA016545] Funding Source: Medline
- NIEHS NIH HHS [R01-ES09098] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058641] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053703, R01AI058300] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009098] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE ON DRUG ABUSE [R21DA014885, R01DA016545] Funding Source: NIH RePORTER
We have demonstrated previously that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) up-regulates Fas and FasL in immune cells, although the molecular mechanisms remain unknown. We investigated the regulation of Fas or FasL promoter by TCDD in EL4 T cells using luciferase reporter constructs. We observed 20 +/- 5- and 14 +/- 4-fold induction of promoter activity for Fas and FasL, respectively, after TCDD exposure. The induction of luciferase was significantly reduced (2 +/- 1-fold) in the presence of alpha-naphthoflavone, an aryl hydrocarbon receptor (AhR) antagonist. We noted the presence of a dioxin response element (DRE) and five nuclear factor-kappa B (NF-kappa B) motifs on Fas promoter, and no DRE but two NF-kappa B motifs on FasL promoter. When we investigated the role of DRE and NF-kappa B, we observed varying levels of luciferase induction (9 +/- 2-fold for DRE and 8 +/- 2-fold for NF-kappa Bs of Fas promoter and 6 +/- 3-fold for NF-kappa Bs of FasL promoter). Mutations in DRE of Fas promoter or NF-kappa Bs of FasL promoter led to decreased luciferase induction, further supporting our results. Probes for DRE or NF-kappa B motifs of Fas and/or FasL promoters demonstrated mobility shift in the presence of nuclear extract from TCDD-treated EL4 cells. Furthermore, we observed supershift in mobility when DRE and NF-kappa B probes were incubated in the presence of anti-mouse AhR, and anti-NF-kappa B (RelA/p65 and p50) antibodies, respectively. Administration of TCDD into mice caused significant increase in Fas and FasL transcripts in thymus and liver. These data demonstrate that TCDD regulates Fas and FasL promoters through DRE and/or NF-kappa B motifs via AhR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据